Fibroklot Tablet is a combination medication containing Tranexamic Acid 500mg and Mefenamic Acid 250mg, designed to effectively manage conditions involving excessive bleeding and pain. Tranexamic Acid is an antifibrinolytic agent that works by inhibiting the breakdown of blood clots, thereby reducing bleeding in disorders such as heavy menstrual bleeding, dental procedures, or post-surgical bleeding. Mefenamic Acid, a nonsteroidal anti-inflammatory drug (NSAID), provides potent analgesic and anti-inflammatory effects, helping to alleviate pain and inflammation associated with menstrual cramps, musculoskeletal pain, or other inflammatory conditions. The synergistic action of these two components makes Fibroklot Tablet particularly useful for patients experiencing painful heavy menstrual bleeding, ensuring both reduction in blood loss and relief from discomfort. It is important to use this medication under medical supervision, as improper use may lead to side effects such as gastrointestinal irritation, allergic reactions, or thrombotic events. Patients with a history of blood clotting disorders, kidney or liver impairment, or hypersensitivity to NSAIDs should consult their healthcare provider before starting Fibroklot Tablet. Adherence to prescribed dosage and duration is essential for optimal therapeutic outcomes and minimizing adverse effects.